The implications of marijuana decriminalization in the brazilian psychiatry context
DOI:
https://doi.org/10.25118/2763-9037.2024.v14.1221Keywords:
cannabis, decriminalization, psychiatry, intoxication, awarenessAbstract
Marijuana is one of the most used psychoactive substances in the world and its decriminalization has been the subsject of debate in Brazil, through the resumption of the process that judges this issue on March 6, 2024. Understanding the relevance of this topic and its possible consequences in thje brazilian pisychiatric context, through this brief overview of the literature, we seek to elucidate possible losses from this decision in the mental health aspect, analyzing studies that evaluated the impact of decriminalization in other countries. Based on data presented, we reiterate the importance of public awareness-raising policies and reinforce the need for participation of entities and authorities in psychiatry in this decision.
Downloads
Metrics
References
Allaf S, Lim JS, Buckley NA, Cairns R. The impact of cannabis legalization and decriminalization on acute poisoning: a systematic review. Addiction. 2023;118(12):2252-74. https://doi.org/10.1111/add.16280 PMID:37496145 PMCID:PMC10952774 DOI: https://doi.org/10.1111/add.16280
Hines LA, Freeman TP, Gage SH, Zammit S, Hickman M, Cannon M, Munafo M, MacLeod J, Heron J. Association of high-potency cannabis use with mental health and substance use in adolescence. JAMA Psychiatry. 2020;77(10):1044-51. https://doi.org/10.1001/jamapsychiatry.2020.1035 PMID:32459328 - PMCID:PMC7254445 DOI: https://doi.org/10.1001/jamapsychiatry.2020.1035
Gobbi G, Atkin T, Zytynski T, Wang S, Askari S, Boruff J, Ware M, Marmorstein N, Cipriani A, Dendukuri N, Mayo N. Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: a systematic review and meta-analysis. JAMA Psychiatry. 2019;76(4):426-34. https://doi.org/10.1001/jamapsychiatry.2018.4500 PMID:30758486 PMCID:PMC6450286 DOI: https://doi.org/10.1001/jamapsychiatry.2018.4500
Jefsen OH, Erlangsen A, Nordentoft M, Hjorthoj C. Cannabis use disorder and subsequent risk of psychotic and nonpsychotic unipolar depression and bipolar disorder. JAMA Psychiatry. 2023;80(8):803-10. https://doi.org/10.1001/jamapsychiatry.2023.1256 PMID:37223912 - PMCID:PMC10209828 DOI: https://doi.org/10.1001/jamapsychiatry.2023.1256
Di Forti M, Marconi A, Carra E, Fraietta S, Trotta A, Bonomo M, Bianconi F, Gardner-Sood P, O'Connor J, Russo M, Stilo SA, Marques TR, Mondelli V, Dazzan P, Pariante C, David AS, Gaughran F, Atakan Z, Iyegbe C, Powell J, Morgan C, Lynskey M, Murray RM. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry. 2015;2(3):233-8. https://doi.org/10.1016/s2215-0366(14)00117-5 PMID:26359901 DOI: https://doi.org/10.1016/S2215-0366(14)00117-5
Published
How to Cite
Conference Proceedings Volume
Section
License
Copyright (c) 2024 Matheus Bortolotto Pansanato, Caroline Saori Matsumi Fukunaga, Pedro Henrique Pereira Alvim, Carolina Parise do Amaral
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
